Instil Bio, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Instil Bio, Inc. (TIL) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.94 million as of 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2023-03-31
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.94M.
- 2021-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $2.20M.
- 2021-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $1.81M.
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.06M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2021-12-31 | $1.94M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.20M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.81M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.06M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |